000 | 01675 a2200409 4500 | ||
---|---|---|---|
005 | 20250514080445.0 | ||
264 | 0 | _c20031119 | |
008 | 200311s 0 0 eng d | ||
022 | _a1566-0702 | ||
024 | 7 |
_a10.1016/S1566-0702(03)00133-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHabecker, Beth A | |
245 | 0 | 0 |
_aGanglionic tyrosine hydroxylase and norepinephrine transporter are decreased by increased sodium chloride in vivo and in vitro. _h[electronic resource] |
260 |
_bAutonomic neuroscience : basic & clinical _cSep 2003 |
||
300 |
_a85-98 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdrenal Glands _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aGanglia, Sympathetic _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNorepinephrine Plasma Membrane Transport Proteins |
650 | 0 | 4 |
_aRNA, Messenger _xantagonists & inhibitors |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSodium Chloride _xmetabolism |
650 | 0 | 4 |
_aSodium Chloride, Dietary _xadministration & dosage |
650 | 0 | 4 |
_aSuperior Cervical Ganglion _xdrug effects |
650 | 0 | 4 |
_aSymporters _xantagonists & inhibitors |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xantagonists & inhibitors |
700 | 1 | _aGrygielko, Eugene T | |
700 | 1 | _aHuhtala, Timothy A | |
700 | 1 | _aFoote, Billy | |
700 | 1 | _aBrooks, Virginia L | |
773 | 0 |
_tAutonomic neuroscience : basic & clinical _gvol. 107 _gno. 2 _gp. 85-98 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1566-0702(03)00133-4 _zAvailable from publisher's website |
999 |
_c12731687 _d12731687 |